Data Insights
By Company Name
No filters selected
By Disease Name
No filters selected
By Drug Name
No filters selected
By Themes
No filters selected
Showing 1 results out of 1
Data Insights
(Ensifentrine + glycopyrrolate) by Verona Pharma for Chronic Obstructive Pulmonary Disease (COPD): Likelihood of Approval
(Ensifentrine + glycopyrrolate) is under clinical development by Verona Pharma and currently in Phase II for Chronic Obstructive Pulmonary Disease...